We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Jazz Settles Seven-Year Xyrem Patent Case with Hikma, Granting License for 2023
Jazz Settles Seven-Year Xyrem Patent Case with Hikma, Granting License for 2023
Jazz Pharmaceuticals settled a seven-year long patent infringement suit over generic copies of its Xyrem solution for narcolepsy, just weeks before the case was scheduled to go to trial.